Literature DB >> 27884600

Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders.

Yun Liang1, Xianying Xing1, Maria A Beamer1, William R Swindell2, Mrinal K Sarkar1, Liza Wolterink Roberts1, John J Voorhees1, J Michelle Kahlenberg3, Paul W Harms4, Andrew Johnston1, Johann E Gudjonsson5.   

Abstract

BACKGROUND: Pustular skin disorders are a category of difficult-to-treat and potentially life-threatening conditions that involve the appearance of neutrophil-rich pustules. The molecular basis of most pustular skin conditions has remained unknown.
OBJECTIVE: We sought to investigate the molecular basis of 3 pustular skin disorders: generalized pustular psoriasis (GPP), palmoplantar pustulosis (PPP), and acute generalized exanthematous pustulosis (AGEP).
METHODS: Microarray analyses were performed to profile genome-wide gene expression of skin biopsy specimens obtained from patients with GPP, PPP, or AGEP and healthy control subjects. Functional enrichment, gene network, and k-means clustering analyses were used to identify molecular pathways dysregulated in patients with these disorders. Immunohistochemistry and immunofluorescence were used to determine protein localization. Quantitative RT-PCR and ELISA were used to determine transcript and secreted cytokine levels. Small interfering RNA was used to decrease transcript levels.
RESULTS: Molecules and pathways related to neutrophil chemotaxis emerged as common alterations in patients with GPP, PPP, and AGEP, which is consistent with the pustular phenotypes. Expression of two 6-transmembrane epithelial antigens of the prostate (STEAP) proteins, STEAP1 and STEAP4, was increased in patients' skin and colocalized with IL-36γ around neutrophilic pustules. STEAP1/4 expression clustered with and positively correlated with that of IL-1, the IL-36 family proteins, and CXCL1/8. STEAP4 expression was activated by cytokines and suppressed by inhibition of mitogen-activated protein kinase kinase 1/2, whereas STEAP1 expression appeared less prone to such dynamic regulation. Importantly, STEAP1/4 knockdown resulted in impaired induction of a broad spectrum of proinflammatory cytokines, including IL-1, IL-36, and the neutrophil chemotaxins CXCL1 and CXCL8. STEAP1/4 knockdown also reduced the ability of keratinocytes to induce neutrophil chemotaxis.
CONCLUSION: Transcriptomic changes in 3 pustular skin disorders, GPP, PPP, and AGEP, converged on neutrophil chemotaxis and diapedesis and cytokines known to drive neutrophil-rich inflammatory processes, including IL-1 and members of the IL-36 family. STEAP1 and STEAP4 positively regulate the induction of proinflammatory neutrophil-activating cytokines.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-transmembrane epithelial antigens of prostate; CXCL1; CXCL8; IL-1; IL-36; Pustular skin disorders; inflammation; neutrophils; transcriptomic profiling

Mesh:

Substances:

Year:  2016        PMID: 27884600      PMCID: PMC5385276          DOI: 10.1016/j.jaci.2016.10.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  61 in total

1.  Bardet-Biedl syndrome.

Authors:  Elizabeth Forsythe; Philip L Beales
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

Review 2.  Hephaestin--a ferroxidase of cellular iron export.

Authors:  Jiri Petrak; Daniel Vyoral
Journal:  Int J Biochem Cell Biol       Date:  2005-01-26       Impact factor: 5.085

Review 3.  The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.

Authors:  Jingsong Wang; Michael A Maldonado
Journal:  Cell Mol Immunol       Date:  2006-08       Impact factor: 11.530

4.  Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.

Authors:  Alexander A Navarini; Laurence Valeyrie-Allanore; Niovi Setta-Kaffetzi; Jonathan N Barker; Francesca Capon; Daniel Creamer; Jean-Claude Roujeau; Peggy Sekula; Michael A Simpson; Richard C Trembath; Maja Mockenhaupt; Catherine H Smith
Journal:  J Invest Dermatol       Date:  2013-01-28       Impact factor: 8.551

5.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

Review 6.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

7.  STEAP4, a gene associated with insulin sensitivity, is regulated by several adipokines in human adipocytes.

Authors:  Xiaohui Chen; Chun Zhu; Chenbo Ji; Yaping Zhao; Chunmei Zhang; Fukun Chen; Chunlin Gao; Jingai Zhu; Lingmei Qian; Xirong Guo
Journal:  Int J Mol Med       Date:  2010-03       Impact factor: 4.101

8.  Ccl2 and Ccl3 mediate neutrophil recruitment via induction of protein synthesis and generation of lipid mediators.

Authors:  Christoph Andreas Reichel; Markus Rehberg; Max Lerchenberger; Nina Berberich; Peter Bihari; Alexander Georg Khandoga; Stefan Zahler; Fritz Krombach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

9.  Evidence for a cross-talk between human neutrophils and Th17 cells.

Authors:  Martin Pelletier; Laura Maggi; Alessandra Micheletti; Elena Lazzeri; Nicola Tamassia; Claudio Costantini; Lorenzo Cosmi; Claudio Lunardi; Francesco Annunziato; Sergio Romagnani; Marco A Cassatella
Journal:  Blood       Date:  2009-11-04       Impact factor: 22.113

Review 10.  The role of TLRs in neutrophil activation.

Authors:  Lynne R Prince; Moira K Whyte; Ian Sabroe; Lisa C Parker
Journal:  Curr Opin Pharmacol       Date:  2011-07-06       Impact factor: 5.547

View more
  7 in total

1.  CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation.

Authors:  Joan Manils; Louise V Webb; Ashleigh Howes; Julia Janzen; Stefan Boeing; Anne M Bowcock; Steven C Ley
Journal:  Elife       Date:  2020-06-29       Impact factor: 8.713

2.  RNA sequencing-based longitudinal transcriptomic profiling gives novel insights into the disease mechanism of generalized pustular psoriasis.

Authors:  Lingyan Wang; Xiaoling Yu; Chao Wu; Teng Zhu; Wenming Wang; Xiaofeng Zheng; Hongzhong Jin
Journal:  BMC Med Genomics       Date:  2018-06-05       Impact factor: 3.063

3.  Signatures of Dermal Fibroblasts from RDEB Pediatric Patients.

Authors:  Arkadii K Beilin; Nadezhda A Evtushenko; Daniil K Lukyanov; Nikolay N Murashkin; Eduard T Ambarchian; Alexander A Pushkov; Kirill V Savostyanov; Andrey P Fisenko; Olga S Rogovaya; Andrey V Vasiliev; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

Review 4.  The Role of the Neutrophilic Network in the Pathogenesis of Psoriasis.

Authors:  Joanna Czerwińska; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

5.  The expression of STEAP4 in peripheral blood predicts the outcome of septic patients.

Authors:  Haiyan Jiang; Yansong Dong; Dajun Yan; Yao Wu; Yue Wang; Yuting Ren; Guomin Mao; Guiwen Liang; Wei Liu; Yang Zhou; Zhongwei Huang; Lei Qi
Journal:  Ann Transl Med       Date:  2021-10

Review 6.  "Autoinflammatory psoriasis"-genetics and biology of pustular psoriasis.

Authors:  Ranjitha Uppala; Lam C Tsoi; Paul W Harms; Bo Wang; Allison C Billi; Emanual Maverakis; J Michelle Kahlenberg; Nicole L Ward; Johann E Gudjonsson
Journal:  Cell Mol Immunol       Date:  2020-08-19       Impact factor: 11.530

7.  STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells.

Authors:  Nicklas Pihlstrøm; Yang Jin; Zeynep Nenseth; Omer F Kuzu; Fahri Saatcioglu
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.